The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis

Fibroblast growth factor 23 (FGF23) is elevated in patients with chronic kidney disease and contributes to left ventricular hypertrophy (LVH). The aim of the analysis was to determine whether this effect is mediated by the renin-angiotensin-aldosterone system (RAAS) in hemodialysis. Serum samples fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dörr, Katharina, Kammer, Michael, Reindl-Schwaighofer, Roman, Lorenz, Matthias, Marculescu, Rodrig, Poglitsch, Marko, Beitzke, Dietrich, Oberbauer, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086596/
https://www.ncbi.nlm.nih.gov/pubmed/35559350
http://dx.doi.org/10.3389/fmed.2022.878730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086596/
https://www.ncbi.nlm.nih.gov/pubmed/35559350
http://dx.doi.org/10.3389/fmed.2022.878730

Ejemplares similares